Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Pharmacological characterization of a homomeric nicotinic acetylcholine receptor formed by Ancylostoma caninum ACR-16.
Choudhary S
,
Tipton JG
,
Abongwa M
,
Brewer MT
,
Chelladurai JJ
,
Musselman N
,
Martin RJ
,
Robertson AP
.
???displayArticle.abstract???
Parasitic nematode infections are treated using anthelmintic drugs, some of which target nicotinic acetylcholine receptors (nAChRs) located in different parasite tissues. The limited arsenal of anthelmintic agents and the prevalence of drug resistance imply that future defense against parasitic infections will depend on the discovery of novel targets and therapeutics. Previous studies have suggested that Ascaris suum ACR-16 nAChRs are a suitable target for the development of antinematodal drugs. In this study, we characterized the pharmacology of the Ancylostoma caninum ACR-16 receptor using two-electrode voltage-clamp electrophysiology. This technique allowed us to study the effects of cholinergic agonists and antagonists on the nematode nAChRs expressed in Xenopus laevis oocytes. Aca-ACR-16 was not sensitive to many of the existing cholinomimetic anthelmintics (levamisole, oxantel, pyrantel, and tribendimidine). 3-Bromocytisine was the most potent agonist (> 130% of the control acetylcholine current) on the Aca-ACR-16 nAChR but, unlike Asu-ACR-16, oxantel did not activate the receptor. The mean time constants of desensitization for agonists on Aca-ACR-16 were longer than the rates observed in Asu-ACR-16. In contrast to Asu-ACR-16, the A. caninum receptor was completely inhibited by DHβE and moderately inhibited by α-BTX. In conclusion, we have successfully reconstituted a fully functional homomeric nAChR, ACR-16, from A. caninum, a model for human hookworm infections. The pharmacology of the receptor is distinct from levamisole-sensitive nematode receptors. The ACR-16 homologue also displayed some pharmacological differences from Asu-ACR-16. Hence, A. caninum ACR-16 may be a valid target site for the development of anthelmintics against hookworm infections.
R21AI092185 National Institute of Allergy and Infectious Diseases, RO1AI047194 National Institute of Allergy and Infectious Diseases, R01 AI047194 NIAID NIH HHS , R21 AI092185 NIAID NIH HHS
Abongwa,
Pharmacological profile of Ascaris suum ACR-16, a new homomeric nicotinic acetylcholine receptor widely distributed in Ascaris tissues.
2016, Pubmed,
Xenbase
Abongwa,
Pharmacological profile of Ascaris suum ACR-16, a new homomeric nicotinic acetylcholine receptor widely distributed in Ascaris tissues.
2016,
Pubmed
,
Xenbase
Abongwa,
A BRIEF REVIEW ON THE MODE OF ACTION OF ANTINEMATODAL DRUGS.
2017,
Pubmed
Aceves,
The mechanism of the paralysing action of tetramisole on Ascaris somatic muscle.
1970,
Pubmed
Albonico,
Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar.
2003,
Pubmed
Albonico,
Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area.
1995,
Pubmed
Altschul,
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
1997,
Pubmed
Aubry,
Aspects of the pharmacology of a new anthelmintic: pyrantel.
1970,
Pubmed
Ballivet,
Nicotinic acetylcholine receptors in the nematode Caenorhabditis elegans.
1996,
Pubmed
,
Xenbase
Bartsch,
The Global Economic and Health Burden of Human Hookworm Infection.
2016,
Pubmed
Bennett,
Reducing intestinal nematode infection: efficacy of albendazole and mebendazole.
2000,
Pubmed
Bethony,
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm.
2006,
Pubmed
Blaxter,
Genes and genomes of Necator americanus and related hookworms.
2000,
Pubmed
Boulin,
Eight genes are required for functional reconstitution of the Caenorhabditis elegans levamisole-sensitive acetylcholine receptor.
2008,
Pubmed
,
Xenbase
Bowman,
Hookworms of dogs and cats as agents of cutaneous larva migrans.
2010,
Pubmed
Brooker,
Hookworm-related anaemia among pregnant women: a systematic review.
2008,
Pubmed
Campbell,
Tailoring Water, Sanitation, and Hygiene (WASH) Targets for Soil-Transmitted Helminthiasis and Schistosomiasis Control.
2018,
Pubmed
Charvet,
Nicotine-sensitive acetylcholine receptors are relevant pharmacological targets for the control of multidrug resistant parasitic nematodes.
2018,
Pubmed
,
Xenbase
Choudhary,
Menthol acts as a positive allosteric modulator on nematode levamisole sensitive nicotinic acetylcholine receptors.
2019,
Pubmed
,
Xenbase
Conder,
Chemotherapy of nematode infections of veterinary importance, with special reference to drug resistance.
1995,
Pubmed
Corringer,
Nicotinic receptors at the amino acid level.
2000,
Pubmed
De Clercq,
Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali.
1997,
Pubmed
Dias,
Evaluation of parasitological and immunological aspects of acute infection by Ancylostoma caninum and Ancylostoma braziliense in mixed-breed dogs.
2013,
Pubmed
Diemert,
Hookworm vaccines.
2008,
Pubmed
Epe,
Intestinal nematodes: biology and control.
2009,
Pubmed
Flohr,
Low efficacy of mebendazole against hookworm in Vietnam: two randomized controlled trials.
2007,
Pubmed
Francis,
The Ror receptor tyrosine kinase CAM-1 is required for ACR-16-mediated synaptic transmission at the C. elegans neuromuscular junction.
2005,
Pubmed
Geerts,
Drug resistance in human helminths: current situation and lessons from livestock.
2000,
Pubmed
Gibson,
Enzymatic assembly of DNA molecules up to several hundred kilobases.
2009,
Pubmed
Giniatullin,
Desensitization of nicotinic ACh receptors: shaping cholinergic signaling.
2005,
Pubmed
Global Burden of Disease Study 2013 Collaborators,
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
2015,
Pubmed
Guyatt,
Hookworm and anaemia prevalence.
2000,
Pubmed
Hewitson,
Vaccination against helminth parasite infections.
2014,
Pubmed
Hotez,
Hookworm and poverty.
2008,
Pubmed
Hotez,
The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases.
2014,
Pubmed
Hotez,
Hookworm infection.
1995,
Pubmed
Jones,
The nicotinic acetylcholine receptor gene family of the nematode Caenorhabditis elegans: an update on nomenclature.
2007,
Pubmed
Kaminsky,
A new class of anthelmintics effective against drug-resistant nematodes.
2008,
Pubmed
Kaplan,
Drug resistance in nematodes of veterinary importance: a status report.
2004,
Pubmed
Keiser,
Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis.
2008,
Pubmed
Knopp,
Nematode infections: soil-transmitted helminths and trichinella.
2012,
Pubmed
Krücken,
Reduced efficacy of albendazole against Ascaris lumbricoides in Rwandan schoolchildren.
2017,
Pubmed
Landmann,
Experimental human infection with the dog hookworm, Ancylostoma caninum.
2003,
Pubmed
Levin,
Nicotinic receptor subtypes and cognitive function.
2002,
Pubmed
Li,
Encoding of both analog- and digital-like behavioral outputs by one C. elegans interneuron.
2014,
Pubmed
Loukas,
Hookworm infection.
2016,
Pubmed
Martin,
Drug resistance and neurotransmitter receptors of nematodes: recent studies on the mode of action of levamisole.
2005,
Pubmed
Martin,
Levamisole receptors: a second awakening.
2012,
Pubmed
,
Xenbase
Menzies,
Risk factors for soil-transmitted helminth infections during the first 3 years of life in the tropics; findings from a birth cohort.
2014,
Pubmed
Petersen,
SignalP 4.0: discriminating signal peptides from transmembrane regions.
2011,
Pubmed
Picciotto,
It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood.
2008,
Pubmed
Prociv,
Human enteric infection with Ancylostoma caninum: hookworms reappraised in the light of a "new" zoonosis.
1996,
Pubmed
Pullan,
Global numbers of infection and disease burden of soil transmitted helminth infections in 2010.
2014,
Pubmed
Pullan,
The global limits and population at risk of soil-transmitted helminth infections in 2010.
2012,
Pubmed
Quick,
Desensitization of neuronal nicotinic receptors.
2002,
Pubmed
Raymond,
Anthelmintic actions on homomer-forming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans.
2000,
Pubmed
,
Xenbase
Reynoldson,
Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia.
1997,
Pubmed
Richmond,
One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction.
1999,
Pubmed
Sievers,
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.
2011,
Pubmed
Thompson,
The structural basis of function in Cys-loop receptors.
2010,
Pubmed
Touroutine,
acr-16 encodes an essential subunit of the levamisole-resistant nicotinic receptor at the Caenorhabditis elegans neuromuscular junction.
2005,
Pubmed
Traversa,
Pet roundworms and hookworms: a continuing need for global worming.
2012,
Pubmed
Verma,
Functional genomics in Brugia malayi reveal diverse muscle nAChRs and differences between cholinergic anthelmintics.
2017,
Pubmed
Wolstenholme,
Drug resistance in veterinary helminths.
2004,
Pubmed
Wolstenholme,
Ion channels and receptor as targets for the control of parasitic nematodes.
2011,
Pubmed
Zheng,
The Ascaris suum nicotinic receptor, ACR-16, as a drug target: Four novel negative allosteric modulators from virtual screening.
2016,
Pubmed
,
Xenbase
de Silva,
Soil-transmitted helminth infections: updating the global picture.
2003,
Pubmed
